GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Corp (FRA:PSH) » Definitions » Common Stock

Sernova (FRA:PSH) Common Stock

: €75.91 Mil (As of Jan. 2024)
View and export this data going back to 2014. Start your Free Trial

Sernova's quarterly common stock increased from Jul. 2023 (€75.95 Mil) to Oct. 2023 (€76.65 Mil) but then declined from Oct. 2023 (€76.65 Mil) to Jan. 2024 (€75.91 Mil).

Sernova's annual common stock increased from Oct. 2021 (€51.31 Mil) to Oct. 2022 (€82.29 Mil) but then declined from Oct. 2022 (€82.29 Mil) to Oct. 2023 (€76.65 Mil).


Sernova Common Stock Historical Data

The historical data trend for Sernova's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Common Stock
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.31 28.71 51.31 82.29 76.65

Sernova Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Common Stock Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 76.74 75.07 75.95 76.65 75.91

Sernova Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Sernova (FRA:PSH) Business Description

Traded in Other Exchanges
Address
700 Collip Circle, The Stiller Centre, Suite 114, London, ON, CAN, N6G 4X8
Sernova Corp is a clinical-stage company developing products for the treatment of chronic debilitating diseases. The company is engaged in the research and development of its proprietary Cell Pouch and associated technologies including immune-protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and or hormones for the long-term treatment of multiple serious, chronic diseases such as diabetes, hemophilia, and thyroid disease.

Sernova (FRA:PSH) Headlines